文献速递关节外科

术前季节性疫苗接种与全关节置换术后并发症之间的关联

Associations Between Preoperative Seasonal Vaccination and Complications After Total Joint Arthroplasty.
PubMed 文献 · J Arthroplasty · 2025-11-27

基于全国登记系统纳入595339例接受全关节置换术的成人,按术前三个月内流感疫苗接种及新冠疫苗接种(术前任意时间或三个月内)分层并行倾向评分匹配。结果显示,术前三个月内流感疫苗接种与90天内科并发症(深静脉血栓、肺炎)及4年假体周围关节感染风险升高相关;新冠疫苗接种与90天肺炎及2至4年假体周围关节感染风险降低相关。作者强调为观察性关联,非因果证明。

要点

  • 术前三个月内流感疫苗接种与90天深静脉血栓(OR 1.38)和肺炎(OR 1.51)风险升高相关。
  • 术前任意时间新冠疫苗接种与2年假体周围关节感染风险降低(OR 0.77)相关,并持续至3年和4年。
  • 术前三个月内新冠疫苗接种与90天肺炎风险降低(OR 0.62)相关。

核心结论

  • 术前新冠疫苗接种与90天肺炎及2、3、4年假体周围关节感染风险降低相关。
  • 近期流感疫苗接种与90天肺炎和深静脉血栓及4年假体周围关节感染风险升高相关。
  • 这些发现提示疫苗类型、接种时机与术后结局之间存在潜在关联,但应解读为观察性关联而非因果证明。

研究设计与样本

  • 使用全国登记系统识别595339例接受全关节置换术的成人。
  • 按术前三个月内流感疫苗接种及术前三个月内或任意时间新冠疫苗接种对患者进行分层。
  • 采用倾向评分匹配控制人口学特征、合并症和近期感染。

主要发现

  • 术前三个月内流感疫苗接种与90天深静脉血栓风险升高相关(OR 1.38,95%CI 1.13至1.69)。
  • 术前三个月内流感疫苗接种与90天肺炎风险升高相关(OR 1.51,95%CI 1.18至1.95)。
  • 术前三个月内流感疫苗接种与4年假体周围关节感染风险升高相关(OR 1.24,95%CI 1.03至1.48)。
  • 术前三个月内新冠疫苗接种与90天肺炎风险降低相关(OR 0.62,95%CI 0.39至0.97),对照为未接种者。
  • 术前任意时间新冠疫苗接种与2年假体周围关节感染风险降低相关(OR 0.77,95%CI 0.67至0.90),并持续至3年和4年;与4年全因翻修风险降低相关(OR 0.81,95%CI 0.71至0.92)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出这些发现应解读为观察性关联而非因果证明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vaccinations against common respiratory pathogens are recommended for the general population. However, associations between respiratory vaccinations and outcomes following total joint arthroplasty (TJA) have not been investigated. METHODS: Using a national registry, 595,339 adults who underwent TJA were identified. Patients were stratified by influenza vaccination within three months before surgery and COVID-19 vaccination within three months of surgery or any time prior. Propensity-score matching controlled for demographics, comorbidities, and recent infections. Primary outcomes included 90-day and 2-, 3-, and 4-year rates of all-cause revision, periprosthetic joint infection (PJI), aseptic loosening, and periprosthetic fracture. The secondary outcomes included 90-day medical complications and mortality. RESULTS: Influenza vaccination within three months of TJA was associated with higher 90-day medical complications, including deep vein thrombosis (odds ratio (OR) 1.38, 95% confidence interval (CI) 1.13 to 1.69) and pneumonia (OR 1.51, 95% CI 1.18 to 1.95), as well as PJI (OR 1.24, 95% CI 1.03 to 1.48) at four years. In contrast, COVID-19 vaccination within three months of TJA was associated with lower odds of pneumonia (OR 0.62, 95% CI 0.39 to 0.97) at 90 days compared to unvaccinated controls. At two years postoperatively, COVID-19 vaccination any time before TJA was associated with lower odds of PJI (OR 0.77, 95% CI 0.67 to 0.90) that persisted at three and four years, and lower odds of all-cause revision at four years (OR 0.81, 95% CI 0.71 to 0.92). CONCLUSIONS: A COVID-19 vaccination before TJA was associated with lower odds of pneumonia at 90 days and PJI at two, three, and four years. In contrast, recent influenza vaccination was associated with higher odds of pneumonia and DVT at 90 days and PJI at four years. These findings highlight potential associations between vaccine type, timing, and postoperative outcomes, but should be interpreted as observational rather than proof of causality.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Bcharah G, Wininger AE, Elsabbagh Z, et al. Associations Between Preoperative Seasonal Vaccination and Complications After Total Joint Arthroplasty. J Arthroplasty. 2025. PMID: 41318039. doi:10.1016/j.arth.2025.11.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。